Penumbra Inc. (PEN)
undefined
undefined%
At close: undefined
247.66
4.72%
Pre-market Jan 07, 2025, 06:58 AM EST

Penumbra Inc. Revenue Breakdown

Quarter Sep 30, 2023Jun 30, 2023Mar 31, 2023Sep 30, 2022Jun 30, 2022Mar 31, 2022Sep 30, 2021Jun 30, 2021Mar 31, 2021Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015
Neuro Revenue 171.41M 108.81M 98.55M 90.32M 84.80M 81.09M 84.65M 83.57M 80.04M 75.92M 58.84M 78.08M 85.42M 329.51M 244.56M 81.47M 74.69M 74.20M 71.43M 182.20M 50.25M 51.35M 47.53M 45.36M 41.28M 105.10M 36.31M
Neuro Revenue Growth +57.52% +10.42% +9.11% +6.50% +4.58% -4.21% +1.29% +4.42% +5.43% +29.03% -24.64% -8.60% -74.08% +34.73% +200.19% +9.08% +0.66% +3.87% -60.79% +262.59% -2.15% +8.03% +4.79% +9.88% -60.72% +189.46% n/a
Peripheral Vascular Revenue 99.54M 152.68M 142.85M 123.36M 123.54M 122.81M 105.47M 100.68M 89.17M 75.16M 46.27M 59.25M 59.84M 212.13M 152.28M 46.97M 37.12M 35.44M 31.27M 78.35M 22.96M 21.75M 19.65M 19.74M 16.64M 30.58M 14.11M
Peripheral Vascular Revenue Growth -34.81% +6.88% +15.80% -0.15% +0.60% +16.45% +4.75% +12.92% +18.64% +62.43% -21.91% -0.99% -71.79% +39.31% +224.21% +26.54% +4.73% +13.35% -60.09% +241.20% +5.57% +10.68% -0.46% +18.69% -45.60% +116.76% n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015
Non-Us Revenue 301.37M 255.42M 219.80M 160.14M 355.22M 290.72M 219.17M 176.10M 127.31M
Non-Us Revenue Growth +17.99% +16.20% +37.25% -54.92% +22.19% +32.64% +24.46% +38.33% n/a
United States Revenue 757.15M 591.72M 527.79M 400.27M n/a n/a n/a n/a n/a
United States Revenue Growth +27.96% +12.11% +31.86% n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 139.74M 139.42M 141.93M 130.02M 125.92M 127.44M 123.08M 115.63M 108.57M 114.61M 110.90M 113.50M 94.40M 90.64M 79.80M 76.60M 76.16M 59.85M 74.45M 74.69M 69.29M 67.67M 61.09M 61.18M 55.93M 54.78M 54.50M 51.47M 45.96M 44.16M 42.72M 41.62M 37.74M 35.88M 33.07M 29.15M 26.75M 26.40M 19.55M
Selling, General, and Administrative Revenue Growth +0.23% -1.77% +9.16% +3.26% -1.19% +3.54% +6.44% +6.50% -5.27% +3.35% -2.29% +20.24% +4.15% +13.58% +4.17% +0.58% +27.24% -19.61% -0.31% +7.79% +2.40% +10.76% -0.14% +9.37% +2.11% +0.51% +5.88% +11.98% +4.07% +3.38% +2.65% +10.28% +5.20% +8.49% +13.43% +8.97% +1.36% +35.04% n/a
Research and Development Revenue 25.20M 24.94M 24.63M 21.94M 20.96M 21.54M 19.99M 17.96M 21.32M 19.56M 20.56M 52.00M 16.73M 17.74M 18.08M 19.45M 34.92M 22.73M 12.95M 12.86M 13.73M 13.46M 11.67M 10.87M 9.09M 8.19M 8.01M 8.40M 8.13M 8.09M 7.03M 6.11M 6.50M 6.26M 5.00M 5.48M 4.56M 4.79M 3.19M
Research and Development Revenue Growth +1.05% +1.28% +12.23% +4.70% -2.69% +7.76% +11.26% -15.74% +9.00% -4.89% -60.46% +210.77% -5.66% -1.87% -7.09% -44.29% +53.68% +75.54% +0.66% -6.35% +2.01% +15.39% +7.36% +19.52% +10.97% +2.25% -4.62% +3.31% +0.47% +15.07% +15.07% -5.91% +3.72% +25.25% -8.81% +20.26% -4.84% +50.17% n/a

Create Price Alert on PEN

Your price alert will notify you when the stock price is above 236.50.

Add to Watchlist